tiprankstipranks
Trending News
More News >
NextCell Pharma AB (SE:NXTCL)
:NXTCL
Sweden Market
Advertisement

NextCell Pharma AB (NXTCL) Cash flow

Compare
0 Followers

NextCell Pharma AB Cash Flow

SE:NXTCL's free cash flow for Q2 2025 was kr-8.02M. For the 2025 fiscal year, SE:NXTCL's free cash flow was decreased by kr10.06M and operating cash flow was kr-6.45M. See a summary of the company’s cash flow.
Cash Flow
Sep 24Sep 23Sep 22Sep 21Sep 20
Operating Cash Flow
kr -37.78Mkr -43.83Mkr -33.31Mkr -25.58Mkr -18.96M
Investing Cash Flow
kr -83.51Kkr -4.10Mkr -9.37Mkr -5.84Mkr -590.01K
Financing Cash Flow
kr 34.63Mkr 835.66Kkr 608.17Kkr 148.63Mkr 21.38M
End Cash Position
kr 46.79Mkr 50.03Mkr 97.12Mkr 139.17Mkr 21.96M
Free Cash Flow
kr -37.86Mkr -47.92Mkr -40.90Mkr -26.30Mkr -19.75M
Currency in SEK

NextCell Pharma AB Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis